8-K/AOther Events

BIOGEN INC. 8-K/A Report (Jan 12, 2004)

Filed January 12, 2004For Securities:BIIB

Summary

This filing is an amendment to a prior 8-K report filed in November 2003, specifically to include pro forma financial information related to the merger between Biogen Inc. and Bridges Merger Corporation. The primary purpose is to present a combined financial picture of the merged entity as if the merger had occurred at an earlier date. Investors can use this information to understand the historical financial performance and position of the combined company before the actual closing date of the merger, allowing for a more informed comparison and analysis of future financial statements.

Key Highlights

  • 1Filing provides unaudited pro forma condensed combined financial statements for the merged Biogen entity.
  • 2The pro forma statements combine historical data from Biogen Inc. and its subsidiary, Bridges Merger Corporation.
  • 3Balance sheet data is presented as if the merger occurred on September 30, 2003.
  • 4Statements of income are presented for the year ended December 31, 2002, and the nine months ended September 30, 2003, reflecting the merger's assumed retroactive effect.
  • 5This amendment supplements a prior 8-K filing from November 12, 2003, concerning the merger.
  • 6Includes consents from PricewaterhouseCoopers LLP, indicating their involvement in the financial reporting.
  • 7References the original merger agreement dated June 20, 2003.

Frequently Asked Questions

This filing is an amendment to a previous report to include unaudited pro forma condensed combined financial statements. These statements show how the merged entity would have looked financially if the merger had occurred at an earlier point in time, providing a basis for historical comparison.

The filing includes a pro forma condensed combined balance sheet as of September 30, 2003, and pro forma condensed combined statements of income for the year ended December 31, 2002, and the nine months ended September 30, 2003. These reflect the combination of Biogen Inc. and Bridges Merger Corporation.

Pro forma financials help investors understand the financial impact of significant events like mergers and acquisitions as if they had happened in the past. This allows for a clearer view of the combined entity's historical performance and financial position before the actual merger closing date, aiding in future analysis and valuation.

The balance sheet is presented as if the merger occurred on September 30, 2003. The statements of income are presented as if the merger occurred on January 1, 2002.